return to small text site

 

US
Europe
US
Europe

press releases

press coverage
electronic press kit
Luveniq
LX201

LX214

LX212
polymer technology
pipeline
other projects

uveitis

corneal transplantation
dry eye syndrome

age-related macular degeneration

mission
history
management
board of directors
investors

About

Ophthalmic Indications
Products &
Technologies

Partners

News & Media
Careers
Contact Us

 

  MANAGEMENT PHOTOS
  Ulrich Grau, Ph.D.
Founder, President & Chief Executive Officer

A. Clarke Atwell
Founder, Chief Operating Officer

Eddy Anglade, M.D.
Founder, Chief Medical Officer

Brett Skolnik
Chief Financial Officer

Manfred Zoltobrocki, Ph.D.
Managing Director, Lux Biosciences GmbH, Frankfurt, Germany
 

 

© 2008 Lux Biosciences, Inc. All rights reserved.                 Web Terms